Stereotaxis Completes Niobe® System Installation at Kakogawa Hospital
August 09, 2016 16:06 ET
|
Stereotaxis, Inc.
ST. LOUIS, Aug. 09, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (OTCQX:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced the launch of its...
Stereotaxis Reports 2016 Second Quarter Financial Results
August 09, 2016 16:05 ET
|
Stereotaxis, Inc.
Ventricular tachycardia procedures increased 24% year over year, representing the 10th consecutive quarter of year-over-year volume growthThree Niobe® system installations completed, including the...
Stereotaxis Common Stock to Begin Trading on OTCQX on August 4, 2016
August 03, 2016 16:15 ET
|
Stereotaxis, Inc.
ST. LOUIS, Aug. 03, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, announced today that its shares...
Stereotaxis to Report Second Quarter 2016 Financial Results on August 9, 2016
August 02, 2016 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, Aug. 02, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced that it will...
Stereotaxis Releases Second Generation V-CAS Deflect™ System in Europe
July 26, 2016 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, July 26, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced the market...
University of Chicago Medicine Creating High-Tech Arrhythmia Technology Suite with Stereotaxis Niobe® ES System
July 13, 2016 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, July 13, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced that the University...
Stereotaxis Niobe® ES System Installed at Texas Children’s Hospital
July 08, 2016 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, July 08, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced that Texas...
Saint Alphonsus Physician Surpasses Procedure Milestone Using Stereotaxis Niobe® ES System
June 14, 2016 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, June 14, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, and Saint Alphonsus Health System...
Stereotaxis to Share its Latest Technology Advancements and Clinical Evidence at Cardiostim 2016 in Nice, France June 8-11
June 07, 2016 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, June 07, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, announced today that it will...
Paracelsus Medical University Clinical Study on Stereotaxis Technology Benefits Recognized at European Cardiac Arrhythmia Society Congress
June 01, 2016 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, June 01, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced the results of a...